BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 17349857)

  • 1. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
    Goto Y; Grace AA
    Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of dopamine in schizophrenia.
    Guillin O; Abi-Dargham A; Laruelle M
    Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The principal features and mechanisms of dopamine modulation in the prefrontal cortex.
    Seamans JK; Yang CR
    Prog Neurobiol; 2004 Sep; 74(1):1-58. PubMed ID: 15381316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-dopamine interaction: an overview.
    Esposito E; Di Matteo V; Di Giovanni G
    Prog Brain Res; 2008; 172():3-6. PubMed ID: 18772025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between N-methyl-D-aspartic acid receptors and D1 dopamine receptors: an important mechanism for brain plasticity.
    Scott L; Aperia A
    Neuroscience; 2009 Jan; 158(1):62-6. PubMed ID: 19000746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin/dopamine interaction in learning.
    Olvera-Cortés ME; Anguiano-Rodríguez P; López-Vázquez MA; Alfaro JM
    Prog Brain Res; 2008; 172():567-602. PubMed ID: 18772051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders.
    Goto Y; Yang CR; Otani S
    Biol Psychiatry; 2010 Feb; 67(3):199-207. PubMed ID: 19833323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.
    Tanaka S
    Neuroscience; 2006 Apr; 139(1):153-71. PubMed ID: 16324800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Under the curve: critical issues for elucidating D1 receptor function in working memory.
    Williams GV; Castner SA
    Neuroscience; 2006 Apr; 139(1):263-76. PubMed ID: 16310964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D4-receptor modulation of cortical neuronal network activity and emotional processing: Implications for neuropsychiatric disorders.
    Lauzon NM; Laviolette SR
    Behav Brain Res; 2010 Mar; 208(1):12-22. PubMed ID: 19948192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain dopamine and brain disorders - and what we have learned from these studies (author's transl)].
    Hornykiewicz O
    Wien Klin Wochenschr; 1980; 92(20):740-3. PubMed ID: 7467350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
    Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B
    Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease.
    Liss B; Roeper J
    Brain Res Rev; 2008 Aug; 58(2):314-21. PubMed ID: 18023878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor inhibitory role of dopamine D1 receptors: implications for ADHD.
    Heijtz RD; Kolb B; Forssberg H
    Physiol Behav; 2007 Sep; 92(1-2):155-60. PubMed ID: 17585966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour.
    Kleppisch T; Feil R
    Handb Exp Pharmacol; 2009; (191):549-79. PubMed ID: 19089345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The brain dopaminergic systems: receptor heterogeneity, functional role and pharmacological regulation].
    Raevskiĭ KS; Sotnikova TD; Gaĭnetdinov RR
    Usp Fiziol Nauk; 1996; 27(4):3-29. PubMed ID: 9019922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent discoveries on the function and plasticity of central dopamine pathways].
    Thibault D; Kortleven C; Fasano C; Dal Bo G; Trudeau LE
    Med Sci (Paris); 2010 Feb; 26(2):165-70. PubMed ID: 20188048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.